Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.41 USD | -5.80% | -6.91% | +5.37% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 44.75M | Capitalization | 1.54B |
---|---|---|---|---|---|
Net income 2024 * | -96M | Net income 2025 * | -78M | EV / Sales 2024 * | - |
Net cash position 2024 * | 238M | Net cash position 2025 * | 151M | EV / Sales 2025 * | 31.1 x |
P/E ratio 2024 * |
-16.8
x | P/E ratio 2025 * |
-23.5
x | Employees | 33 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.61% |
Latest transcript on Soleno Therapeutics, Inc.
1 day | -5.80% | ||
1 week | -6.91% | ||
Current month | +0.78% | ||
1 month | -2.51% | ||
3 months | +0.66% | ||
6 months | +14.07% | ||
Current year | +5.37% |
Managers | Title | Age | Since |
---|---|---|---|
Anish Bhatnagar
CEO | Chief Executive Officer | 56 | 05-12-31 |
James Mackaness
DFI | Director of Finance/CFO | 60 | 19-11-13 |
Ernest Mario
CHM | Chairman | 85 | 07-08-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ernest Mario
CHM | Chairman | 85 | 07-08-02 |
Bill Harris
BRD | Director/Board Member | 65 | 14-06-01 |
Anish Bhatnagar
CEO | Chief Executive Officer | 56 | 05-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 42.41 | -5.80% | 390,682 |
24-06-13 | 45.02 | -2.47% | 196,179 |
24-06-12 | 46.16 | -0.58% | 332,342 |
24-06-11 | 46.43 | -1.34% | 461,304 |
24-06-10 | 47.06 | +3.29% | 327,648 |
Delayed Quote Nasdaq, June 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.37% | 1.54B | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- SLNO Stock